Mammoth Biosciences
Mammoth Biosciences Raises $195M in Series D
Quick Facts
Mammoth Biosciences Raises $195M in Series D
Mammoth Biosciences has successfully raised $195M in a Series D at a $1B valuation led by Decheng Capital, Greenoaks Capital, Mayfield, NFX, 8VC, Plum Alley Ventures.
Company Overview
Mammoth Biosciences is a Biotech company headquartered in 3478 Buskirk Avenue, Pleasant Hill, CA 94523, founded in 2017 with 150+ employees.
CRISPR-based diagnostics and therapeutics
Fundraising Details
- Amount Raised: $195M
- Round Type: Series D
- Valuation: $1B
- Date: 2024-08-11
- Investors: Decheng Capital, Greenoaks Capital, Mayfield, NFX, 8VC, Plum Alley Ventures
About Mammoth Biosciences
CRISPR-based diagnostics and therapeutics The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 3478 Buskirk Avenue, Pleasant Hill, CA 94523
- Founded: 2017
- Team Size: 150+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Mammoth Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Mammoth Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1B valuation marks an important milestone for Mammoth Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Mammoth Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-08-11. For more information about Mammoth Biosciences, visit their headquarters at 3478 Buskirk Avenue, Pleasant Hill, CA 94523.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.